Neuropsychiatric Symptoms and Quality of Life in Alzheimer Disease-Reference-Cited by-同舟云学术

Neuropsychiatric Symptoms and Quality of Life in Alzheimer Disease

Published:2005-06 Issue:6 Volume:13 Page:469-474
ISSN:1064-7481
Container-title:The American Journal of Geriatric Psychiatry
language:en
Short-container-title:The American Journal of Geriatric Psychiatry

Author:

Shin Il-Seon,Carter Michele,Masterman Donna,Fairbanks Lynn,Cummings Jeffrey L.

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Geriatrics and Gerontology

Reference25 articles.

1. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment;Finkel;Int Psychogeriatr,1996

2. Assessing quality of life in older adults with cognitive impairment;Logsdon;Psychosom Med,2002

3. Quality of life for people with dementia living in residential and nursing home care: the impact of performance on activities of daily living, behavioral and psychological symptoms, language skills, and psychotropic drugs;Ballard;Int Psychogeriatr,2001

4. Determinants of carer stress in Alzheimer's disease;Donaldson;Int J Geriatr Psychiatry,1998

5. Quality of life in patients with Alzheimer's disease as reported by patient proxies;Albert;J Am Geriatr Soc,1996

Cited by 179 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can infliximab serve as a new therapy for neuropsychiatric symptoms?;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-09-03

2. Happiness, positive emotions, and subjective well-being in dementia;Frontiers in Neurology;2024-07-23

3. Distribution of neuropsychiatric profiles and comorbid diseases in dementia subtypes;The European Research Journal;2024-07-04

4. Effects of the discontinuation of antihypertensive treatment on neuropsychiatric symptoms and quality of life in nursing home residents with dementia (DANTON): a multicentre, open-label, blinded-outcome, randomised controlled trial;Age and Ageing;2024-07

5. Clinical Pipelines for Alzheimer’s Disease Psychosis and Agitation;Chemical and Pharmaceutical Bulletin;2024-07-01